(Q36451062)

14 August 2017

1 reference

title

HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy (English)

1 reference

14 August 2017

0 references

anti-retroviral agent

0 references

author name string

Röling J

1

1 reference

14 August 2017

Schmid H

2

1 reference

14 August 2017

Fischereder M

3

1 reference

14 August 2017

Draenert R

4

1 reference

14 August 2017

Goebel FD

5

1 reference

14 August 2017

language of work or name

English

0 references

publication date

11 April 2006

1 reference

Clinical Infectious Diseases

14 August 2017

published in

1 reference

14 August 2017

volume

42

1 reference

14 August 2017

issue

10

1 reference

14 August 2017

page(s)

1488-1495

1 reference

Incidence and etiology of acute renal failure among ambulatory HIV-infected patients.

14 August 2017

cites work

1 reference

Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations

21 January 2018

1 reference

Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women

21 January 2018

1 reference

Predictors of proteinuria and renal failure among women with HIV infection

21 January 2018

1 reference

Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy

21 January 2018

1 reference

Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease

21 January 2018

1 reference

The clinical spectrum of renal disease associated with human immunodeficiency virus

21 January 2018

1 reference

Course and prognosis of human immunodeficiency virus-associated nephropathy

21 January 2018

1 reference

Up-regulation of Duffy antigen receptor expression in children with renal disease

21 January 2018

1 reference

HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection

21 January 2018

1 reference

Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy

21 January 2018

1 reference

Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy

21 January 2018

1 reference

Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition

21 January 2018

1 reference

von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura

21 January 2018

1 reference

The HIV-associated renal diseases: current insight into pathogenesis and treatment

21 January 2018

1 reference

HIV-associated immune complex glomerulonephritis with "lupus-like" features: a clinicopathologic study of 14 cases

21 January 2018

1 reference

Pattern of glomerular involvement in human immunodeficiency virus—infected patients: An Italian study

21 January 2018

1 reference

IgA nephropathy associated with human immuno deficiency virus infection: antiproteinuric effect of captopril

21 January 2018

1 reference

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group

21 January 2018

1 reference

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study

21 January 2018

1 reference

Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003.

21 January 2018

1 reference

The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection

21 January 2018

1 reference

21 January 2018

1 reference

African tick-bite fever. An imported spotless rickettsiosis

21 January 2018

1 reference

Risk factors for urological symptoms in a cohort of users of the HIV protease inhibitor indinavir sulfate: the ATHENA cohort

21 January 2018

1 reference

Incidence and risk factors for the development of indinavir-associated renal complications

21 January 2018

1 reference

Urinary stones in HIV-1-positive patients treated with indinavir

21 January 2018

1 reference

Renal tolerance of combined treatment with foscarnet and indinavir

21 January 2018

1 reference

Persistent leukocyturia and loss of renal function in a prospectively monitored cohort of HIV-infected patients treated with indinavir.

21 January 2018

1 reference

Persistent sterile leukocyturia is associated with impaired renal function in human immunodeficiency virus type 1-infected children treated with indinavir

21 January 2018

1 reference

Changes in renal function associated with indinavir

21 January 2018

1 reference

Acute tubulointerstitial nephritis attributable to indinavir therapy

21 January 2018

1 reference

21 January 2018

Indinavir nephropathy

1 reference

Renal atrophy associated with long-term treatment with indinavir

21 January 2018

1 reference

Ritonavir and renal failure

21 January 2018

1 reference

Renal failure after treatment with ritonavir

21 January 2018

1 reference

Renal calculi developing de novo in a patient taking saquinavir

21 January 2018

1 reference

Acute interstitial nephritis associated with atazanavir, a new protease inhibitor

21 January 2018

1 reference

Fanconi syndrome and renal failure induced by tenofovir: a first case report

21 January 2018

1 reference

Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity.

21 January 2018

1 reference

Renal lesions in HIV-1-positive patient treated with tenofovir

21 January 2018

1 reference

21 January 2018

1 reference

Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome

21 January 2018

1 reference

Acute tubular necrosis in a patient receiving tenofovir

21 January 2018

1 reference

Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity?

21 January 2018

1 reference

Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure

21 January 2018

1 reference

21 January 2018

1 reference

Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases

21 January 2018

1 reference

Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study

21 January 2018

1 reference

Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions

21 January 2018

1 reference

Drug-induced Fanconi's syndrome.

21 January 2018

1 reference

Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study

21 January 2018

1 reference

Progression of renal impairment under therapy with tenofovir

21 January 2018

1 reference

Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment

21 January 2018

1 reference

Antiretroviral therapy with tenofovir is associated with mild renal dysfunction

21 January 2018

1 reference

Renal tubular transporters and antiviral drugs: an update

21 January 2018

1 reference

Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs

21 January 2018

1 reference

MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs

21 January 2018

1 reference

Antiviral drug-induced nephrotoxicity

21 January 2018

1 reference

Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5

21 January 2018

1 reference

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

21 January 2018

1 reference

Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial

21 January 2018

1 reference

Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study

21 January 2018

1 reference

Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study

21 January 2018

1 reference

Fanconi syndrome associated with didanosine therapy

21 January 2018

1 reference

Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

Severe efavirenz-induced hypersensitivity syndrome (not-DRESS) with acute renal failure.

21 January 2018

1 reference

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/503566

1 reference

14 August 2017

1 reference